Hypertension is the leading cause of cardiovascular disease and premature death
worldwide. Owing to the widespread use of antihypertensive medications, global mean …

There is increasing evidence of the influence of the gut microbiota on hypertension and its
complications, such as chronic kidney disease, stroke, heart failure, and myocardial …

In the Guidelines, differentiation between optimal and essential standards were not always
possible, and were made in sections where it was most practical and sensible. The …

Elevated blood pressure remains the single biggest risk factor contributing to the global
burden of disease and mortality. May Measurement Month is an annual global screening …

Background Renal denervation (RDN) is under investigation for treatment of uncontrolled
hypertension and might represent an attractive treatment for patients with high …

Arterial hypertension is the most prevalent modifiable risk factor associated with
cardiovascular morbidity and mortality. Although antihypertensive drugs are widely …

Background Non-steroidal anti-inflammatory drugs (NSAIDs) are one of the most commonly
prescribed medications, but they are associated with a number of serious adverse effects …

The Asia Renal Denervation Consortium consensus conference of Asian physicians actively
performing renal denervation (RDN) was recently convened to share up-to-date information …

Approximately 25% of the population in Taiwan has hypertension, and the rate has
increased over time. Although age‐standardized cardiovascular mortality has decreased …

Background and aim To estimate the prevalence of cardiovascular (CV) disease and CV risk
factors among Polish patients. Methods A nationwide cross-sectional study …